Intrinsic Value of S&P & Nasdaq Contact Us

POINT Biopharma Global Inc. PNT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.75
+10%

POINT Biopharma Global Inc. (PNT) has 17 known insider and institutional holders on record. The largest holder is MCCANN JOE A. with 3,494,153 shares. Other notable holders include FLESHNER NEIL E. and RA CAPITAL MANAGEMENT, L.P..

PNT Insider Ownership

Top Holder
MCCANN JOE A.
3,494,153 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Mccann Joe A. Chief Executive Officer 3,494,153 2023-11-07
100%
2 Fleshner Neil E. Chief Medical Officer 2,773,045 2023-11-02
79%
3 Ra Capital Management, L.p. Director 1,098,318 2021-06-30
31%
4 Kolchinsky Peter Chief Executive Officer 1,098,318 2021-06-30
31%
5 Bvf Partners L P/il 10 Percent Owner 896,366 2023-11-06
26%
6 Jensen Jessica D. EVP Clinical Development 136,055 2023-03-30
4%
7 Demers William L. Chief Financial Officer 131,355 2023-03-30
4%
8 Kelly Justyna Chief Operating Officer 98,358 2023-03-30
3%
9 Martell Bridget A Director 80,503 2023-06-14
2%
10 Gottlieb Michael M. Chief Commercial Officer 48,000 2021-07-08
1%
11 Goodman Jonathan R. Director 44,749 2023-06-05
1%
12 Margolin Yael Director 44,749 2023-06-05
1%
13 Hogue Gerald L. Director 44,749 2023-06-05
1%
14 Malik Rajesh Director 44,749 2023-06-05
1%
15 Silber Allan C Executive Chairman 38,087 2023-11-07
1%
16 Gilmour Margaret E. Director 25,000 2021-07-08
1%
17 Lubner David Charles Director 3,600 2023-12-27
0%

No ownership data available for PNT.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message